Cargando…

Propofol suppresses the His‐ventricular conduction in paediatric patients

WHAT IS KNOWN AND OBJECTIVE: Propofol is the most commonly used intravenous anaesthetic worldwide and is considered to be safe for all ages. However, there have been some reports that propofol induces severe atrioventricular (AV) blocks in humans and some studies demonstrated that propofol suppresse...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsushima, Mayuka, Kimura, Seishi, Kitaura, Atsuhiro, Hamasaki, Shinichi, Iwamoto, Tatsushige, Mino, Takashi, Masui, Kenichi, Nakao, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983984/
https://www.ncbi.nlm.nih.gov/pubmed/33098128
http://dx.doi.org/10.1111/jcpt.13302
_version_ 1783667979515330560
author Matsushima, Mayuka
Kimura, Seishi
Kitaura, Atsuhiro
Hamasaki, Shinichi
Iwamoto, Tatsushige
Mino, Takashi
Masui, Kenichi
Nakao, Shinichi
author_facet Matsushima, Mayuka
Kimura, Seishi
Kitaura, Atsuhiro
Hamasaki, Shinichi
Iwamoto, Tatsushige
Mino, Takashi
Masui, Kenichi
Nakao, Shinichi
author_sort Matsushima, Mayuka
collection PubMed
description WHAT IS KNOWN AND OBJECTIVE: Propofol is the most commonly used intravenous anaesthetic worldwide and is considered to be safe for all ages. However, there have been some reports that propofol induces severe atrioventricular (AV) blocks in humans and some studies demonstrated that propofol suppressed the cardiac conduction system in animals. A precise mechanism by which the block is induced has not been elucidated yet in humans. The objective of this study was to investigate the effects of propofol on the cardiac conduction system and the cardiac autonomic nervous balance in children. METHODS: We enrolled 23 paediatric patients (age: 6‐15 years; males: 16, females: 7) who were scheduled to undergo radiofrequency catheter ablation (RFCA) under general anaesthesia. Anaesthesia was induced with 2 mg/kg propofol and 0.5 µg/kg/min remifentanil, and tracheal intubation was performed with the aid of 1 mg/kg rocuronium. Anaesthesia was maintained with 5‐7 mg/kg/h propofol and 0.2 µg/kg/min remifentanil during the RFCA. After the completion of the RFCA, anaesthesia was further maintained with 5 mg/kg/h propofol and 0.2 µg/kg/min remifentanil for at least 10 min (LC: low propofol concentration state), followed by the injection of 2 mg/kg propofol and the infusion of 10 mg/kg/h propofol for 10 min (HC: high propofol concentration state). The sinus node recovery time (SNRT), sinoatrial conduction time (SACT), atrial‐His (AH) interval and the His‐ventricular (HV) interval were measured at the end of both the LC and HC. Cardiac autonomic regulation was simultaneously assessed based on heart rate variability. RESULTS AND DISCUSSION: Propofol significantly suppressed intrinsic cardiac HV conduction, but did not affect the SNRT, SACT or the AH interval. As HV blocks, which occur below the His bundle, are often life‐threatening, the HV conduction delay may be a cause of severe AV blocks induced by propofol. Propofol directly suppressed parasympathetic nerve activity, and sympathetic nerve activity was also suppressed. WHAT IS NEW AND CONCLUSION: These results indicate that propofol suppresses the HV conduction and might help to elucidate the mechanism by which propofol causes lethal AV blocks.
format Online
Article
Text
id pubmed-7983984
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79839842021-03-24 Propofol suppresses the His‐ventricular conduction in paediatric patients Matsushima, Mayuka Kimura, Seishi Kitaura, Atsuhiro Hamasaki, Shinichi Iwamoto, Tatsushige Mino, Takashi Masui, Kenichi Nakao, Shinichi J Clin Pharm Ther Original Articles WHAT IS KNOWN AND OBJECTIVE: Propofol is the most commonly used intravenous anaesthetic worldwide and is considered to be safe for all ages. However, there have been some reports that propofol induces severe atrioventricular (AV) blocks in humans and some studies demonstrated that propofol suppressed the cardiac conduction system in animals. A precise mechanism by which the block is induced has not been elucidated yet in humans. The objective of this study was to investigate the effects of propofol on the cardiac conduction system and the cardiac autonomic nervous balance in children. METHODS: We enrolled 23 paediatric patients (age: 6‐15 years; males: 16, females: 7) who were scheduled to undergo radiofrequency catheter ablation (RFCA) under general anaesthesia. Anaesthesia was induced with 2 mg/kg propofol and 0.5 µg/kg/min remifentanil, and tracheal intubation was performed with the aid of 1 mg/kg rocuronium. Anaesthesia was maintained with 5‐7 mg/kg/h propofol and 0.2 µg/kg/min remifentanil during the RFCA. After the completion of the RFCA, anaesthesia was further maintained with 5 mg/kg/h propofol and 0.2 µg/kg/min remifentanil for at least 10 min (LC: low propofol concentration state), followed by the injection of 2 mg/kg propofol and the infusion of 10 mg/kg/h propofol for 10 min (HC: high propofol concentration state). The sinus node recovery time (SNRT), sinoatrial conduction time (SACT), atrial‐His (AH) interval and the His‐ventricular (HV) interval were measured at the end of both the LC and HC. Cardiac autonomic regulation was simultaneously assessed based on heart rate variability. RESULTS AND DISCUSSION: Propofol significantly suppressed intrinsic cardiac HV conduction, but did not affect the SNRT, SACT or the AH interval. As HV blocks, which occur below the His bundle, are often life‐threatening, the HV conduction delay may be a cause of severe AV blocks induced by propofol. Propofol directly suppressed parasympathetic nerve activity, and sympathetic nerve activity was also suppressed. WHAT IS NEW AND CONCLUSION: These results indicate that propofol suppresses the HV conduction and might help to elucidate the mechanism by which propofol causes lethal AV blocks. John Wiley and Sons Inc. 2020-10-24 2021-04 /pmc/articles/PMC7983984/ /pubmed/33098128 http://dx.doi.org/10.1111/jcpt.13302 Text en © 2020 The Authors. Journal of Clinical Pharmacy and Therapeutics published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Matsushima, Mayuka
Kimura, Seishi
Kitaura, Atsuhiro
Hamasaki, Shinichi
Iwamoto, Tatsushige
Mino, Takashi
Masui, Kenichi
Nakao, Shinichi
Propofol suppresses the His‐ventricular conduction in paediatric patients
title Propofol suppresses the His‐ventricular conduction in paediatric patients
title_full Propofol suppresses the His‐ventricular conduction in paediatric patients
title_fullStr Propofol suppresses the His‐ventricular conduction in paediatric patients
title_full_unstemmed Propofol suppresses the His‐ventricular conduction in paediatric patients
title_short Propofol suppresses the His‐ventricular conduction in paediatric patients
title_sort propofol suppresses the his‐ventricular conduction in paediatric patients
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983984/
https://www.ncbi.nlm.nih.gov/pubmed/33098128
http://dx.doi.org/10.1111/jcpt.13302
work_keys_str_mv AT matsushimamayuka propofolsuppressesthehisventricularconductioninpaediatricpatients
AT kimuraseishi propofolsuppressesthehisventricularconductioninpaediatricpatients
AT kitauraatsuhiro propofolsuppressesthehisventricularconductioninpaediatricpatients
AT hamasakishinichi propofolsuppressesthehisventricularconductioninpaediatricpatients
AT iwamototatsushige propofolsuppressesthehisventricularconductioninpaediatricpatients
AT minotakashi propofolsuppressesthehisventricularconductioninpaediatricpatients
AT masuikenichi propofolsuppressesthehisventricularconductioninpaediatricpatients
AT nakaoshinichi propofolsuppressesthehisventricularconductioninpaediatricpatients